Sivakumar R, Chan M, Shin J, Nishida Aoki N, Kenerson H, Elemento O, et al. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery. Oncoimmunology. 2019;8:e1670019 pubmed publisher

Broos K, Lecocq Q, Keersmaecker B, Raes G, Corthals J, Lion E, et al. Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production. Vaccines (Basel). 2019;7: pubmed publisher

Porichis F, Hart M, Zupkosky J, Barblu L, Kwon D, McMullen A, et al. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions. J Virol. 2014;88:2508-18 pubmed publisher

Hegde S, Lockridge J, Becker Y, Ma S, Kenney S, Gumperz J. Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands. J Autoimmun. 2011;37:28-38 pubmed publisher

Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga M, Kaminski M, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 2009;5:e1000313 pubmed publisher

Cai G, Karni A, Oliveira E, Weiner H, Hafler D, Freeman G. PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cell Immunol. 2004;230:89-98 pubmed

Brown J, Dorfman D, Ma F, Sullivan E, Munoz O, Wood C, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol. 2003;170:1257-66 pubmed